Identifying SUMO Protease Targets and Investigating E3 Ligase Interactions by Guillotte, Mark
W&M ScholarWorks 
Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 
2014 
Identifying SUMO Protease Targets and Investigating E3 Ligase 
Interactions 
Mark Guillotte 
College of William & Mary - Arts & Sciences 
Follow this and additional works at: https://scholarworks.wm.edu/etd 
 Part of the Molecular Biology Commons 
Recommended Citation 
Guillotte, Mark, "Identifying SUMO Protease Targets and Investigating E3 Ligase Interactions" (2014). 
Dissertations, Theses, and Masters Projects. Paper 1539626956. 
https://dx.doi.org/doi:10.21220/s2-wrgj-tz43 
This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M 
ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
Identifying SUMO protease targets and investigating E3 ligase interactions
Mark Guillotte 
Baton Rouge, Louisiana
Bachelors of Science, Louisiana State University, 2010
A Thesis presented to the Graduate Faculty 
of the College of William and Mary in Candidacy for the Degree of
Master of Science
Department of Biology
The College of William and Mary 
January 2014
APPROVAL PAGE
This Thesis is submitted in partial fulfillment of 
the requirements for the degree of 
Master of Science
Mark Guillotte
Approved by^he Committee, January 2014
(be Chair
Associate Professor Oliver Kerseher, Biology 
The College of William and Mary
'oVYwG..GSl1m>.
rofessor Lizabeth Allison, Biology 
The College of William and Mary
Professor Diane Shakes, Biology 
The College of William and Mary
Assistant Professor Shanta Hinton,
----------
Biology
The College of William and Mary
COMPLIANCE PAGE
Research approved by
Steve Kaattari 
Protocol number(s): IBC-2012-10-08-8156-opkers
Date(s) of approval: 2013-11-02
ABSTRACT
Posttranslational modification by the Small Ubiquitin-like Modifier (SUMO) is a 
pervasive mechanism for controlling protein function. SUMO is conserved from 
yeast to man and is fundamental to eukaryotic life. Sumoylation is a dynamic 
process and regulation of SUMO conjugate levels is accomplished in two ways. 
First, SUMO can be removed from conjugate proteins by SUMO specific 
proteases. In budding yeast Saccharomyces cerevisiae, the SUMO protease 
Ulp1 is responsible for removing SUMO from target proteins and processing 
SUMO precursor peptides. Ulp1 is essential for cell cycle progression; 
however, few specific Ulp1 substrates have been identified. The first part of this 
thesis utilized a substrate-trapping mutant of Ulp1, known as the U-Tag, to 
identify candidate Ulp1 substrates. Our analysis has identified 32 candidate 
Ulp1 substrates includingBmhl, a regulatory molecule that interacts with the 
Anaphase Promoting Complex (APC). Bmh1 is a 14-3-3 protein that associates 
with an APC component and was previously shown to be sumoylated. These 
findings suggest a mechanism by which a SUMO protease can contribute to 
cell cycle regulation. The second method cells use to regulate SUMO 
conjugate levels is by destruction of sumoylated proteins in the ubiquitin 
proteasome system. Recent work has identified a novel class of SUMO- 
Targeted Ubiquitin Ligases (STUbLs) which selectively 
ubiquitylatepolysumoylated proteins. In yeast, the STUbL heterodimer Slx5- 
Slx8 has an important role in SUMO-targeted degradation. Slx5 is the targeting 
domain of the STUbL complex and it usually resides in the nucleus where it 
plays a key role in genome stability and DNA damage repair. Continuing work 
in the lab has identified a physical interaction between Slx5 and the E3 SUMO 
ligase known as Siz1. The data herein describes the functional consequences 
of this interaction and demonstrates that slx5A cells accumulate sumoylated 
and phosphorylated Siz1. These data suggestthat three different modifications 
are involved in Siz1 regulation (SUMO, ubiquitin, and phosphorylation). Finally, 
our data indicate that Siz1 is degraded in an Slx5 dependent manner when 
nuclear export is blocked during G2/M. In summary, part two of this thesis 
identifies targeting and localization domains in Slx5 and additionally provides 
evidence that STUbLs may regulate levels of an E3 SUMO ligase.
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Chapter 1. Introduction
Posttranslational modification
Eukaryotic cells enhance the diversity of their proteome through the 
covalent addition of chemical groups or peptides. For example, methyl groups, 
acetyl groups, nitrosyl compounds, carbohydrates, lipids, or small proteins can 
become covalently linked to the side chain of specific amino acids in a process 
known as posttranslational modification. It is estimated that over 5% of the 
proteome is dedicated to facilitating more than 200 types of posttranslational 
modification (Walsh, 2006).
Posttranslational modification can modulate protein function in response to 
internal cellular cues or external stimuli. The most common posttranslational 
modification is phosphorylation. Mediated by a group of enzymes called kinases, 
phosphorylation links an inorganic phosphate group donated by ATP to the side 
chain of specific amino acids; most commonly serine, threonine, and tyrosine. A 
phosphate group increases the local negative charge of residues to which they 
are linked. Changes in protein charge profile can induce changes in conformation 
or interactions which, in turn, modify protein function. One well studied example 
is receptor signaling carried out by members of the mitogen activated protein 
kinase (MAPK) family. MAPKs are well known for transmitting information across 
the plasma membrane and into the nucleus using a trio of kinases acting 
sequentially to begin a signal cascade. Phosphorylation is a reversible process
l
and removal of phosphate molecules is facilitated by a group of enzymes called 
phosphatases. In humans, there are more than 500 known kinases and over 150 
phosphatases (Lothrop, Torres, & Fuchs, 2013; Walsh, 2006)
This thesis will focus on modification by two types of small peptide 
modifiers; SUMO and ubiquitin. Sumoylation and ubiquitylation are discussed in 
detail below.
Ubiquitin
One form of posttranslational modification that is widely used by 
eukaryotic cells is the attachment of small proteins to the side chains of specific 
residues such as lysine. The first protein modifier discovered, described in 1975, 
is a 76 residue peptide known as ubiquitin which was named for its ubiquitous 
distribution throughout the eukaryotic domain (Goldstein et al. 1975). Initially 
discovered as a means to target proteins for proteasomal degradation, 
ubiquitylation is now also known to regulate protein interactions, localization and 
activity (Jackson & Durocher 2013). In yeast, ubiquitin is expressed as a 
polyubiquitin fusion that must be processed by deubiquitylating enzymes (DUBs) 
into conjugation competent monomers (Finley et al. 2012; Ozkaynak et al. 1984).
Attachment of ubiquitin to target proteins is an energy dependent process 
carried out by a three enzyme cascade consisting of an E1 activating enzyme, 
and E2 conjugating enzyme and an E3 ligase (model 1). Ubiquitylation is 
reversible and processing of ubiquitin fusion protein is carried out by 
deubiquitylating enzymes (DUBs) (model 1). Ubiquitin is the founding member of
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a conserved family of modifiers named ubiquitin-like proteins (Ubls). This family 
contains at least 10 proteins which are all modestly related in sequence but, in 
some cases, share a common three-dimensional structure (Kerscher et al. 2006).
SUMO
A second posttranslational modifier, known as SUMO, shares about 18% 
sequence identity with ubiquitin. There are three SUMO isoforms in humans but 
only one in yeast, Smt3. In this thesis, Smt3 will be refered to as yeast SUMO; 
the yeast version of this posttranslational modifier. SUMO is a 110-amino acid 
protein, and the second most widely characterized member of the Ubl family. It is 
highly conserved among eukaryotes and essential for life (Johnson,
2004).Sumoylation has been shown to play a key role in facilitating DNA repair, 
cell cycle progression, protein stability, transcription, and the stress response 
(Kerscher et al. 2006). However, it also holds important roles in the assembly of 
protein complexes.
SUMO processing and attachment
Initially, SUMO is expressed as a precursor that must be processed by a 
SUMO protease into its conjugation competent form. Processing in yeast 
involves the removal of three C-terminal residues by the SUMO-specific protease 
Ulp1. This cleavage makes SUMO conjugation competent by exposing a di­
glycine repeat that is the site of substrate attachment. After processing, 
attachment is carried out by a three enzyme cascade reminiscent of the ubiquitin 
system described earlier(model 1). To initiate substrate modification, SUMO
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must first be activated by an E1 activating enzyme which in yeast is a 
heterodimer consisting of Aos1 and Uba2. The E1 uses ATP to form a high 
energy thioester bond between the terminal glycine carboxylate and a catalytic 
cysteine residue of the enzyme. This high energy bond is then transferred to a 
catalytic cysteine residue on an E2 conjugating enzyme known as Ubc9. Finally, 
Ubc9 transfers the SUMO to a lysine side chain on its target protein, with the 
help of an E3 SUMO ligase that facilitates the conjugation onto specific proteins. 
Conjugation usually occurs within the consensus sequence qj-K-x-D/E where qj is 
hydrophobic, K is the lysine conjugated to SUMO, x is any amino acid, and D/E is 
an acidic residue (Kerscher et al. 2006).Single SUMO molecules can be attached 
to the same protein, or chains can form on residues within the tertiary structure of 
SUMO monomers.
Of particular interest are four SUMO ligases in yeast; Siz1, Siz2, Mms21, 
and the meiotic-specific Zip3. All four are members of the Siz/PIAS-RING (SP­
RING) ligase family that shares sequence similarity to ubiquitin’s Really 
interesting New Gene (RING) ligase family and function in a similar manner 
(Johnson &Gupta 2001; Takahashi et al. 2001; Zhao & Blobel 2005; Cheng et al.
2006). SUMO ligases recruit SUMO charged E2 enzymes into a complex with the 
substrate to facilitate conjugation. Although the SUMO E2 enzyme can catalyze 
sumoylation alone, SUMO E3 ligases enhance conjugation to specific substrates 
and deletions of Siz1 and Siz2 are non-lethal but have been linked to growth 
defects and sensitivity to environmental stress. Siz1 and Siz2 are responsible for 
over 90% of global sumoylation and they show considerable substrate overlap
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(Chen et al. 2011; Silver et al. 2011). There are, however, substrates specific to 
either Siz1 or Siz2. For example, Siz1 is required for sumoylation of the septin 
proteins Cdc3, Cdc11 and Shs1 (Johnson & Blobel, 1999).
SUMO removal
The covalent attachment of SUMO to specific substrates or other SUMO 
proteins is a reversible process. SUMO can be removed from its substrates by 
the same SUMO protease that renders it conjugation competent, Ulp1. This 
protease cleaves the isopeptide bond between the SUMO carboxy-terminal 
glycine and the lysine side chain to which it is linked. Cleavagereleases SUMO 
monomer and the target protein in its initial conformation. A second SUMO 
protease in yeast is called Ulp2. Ulp1 and Ulp2, have overlapping but non­
identical substrates specificities but only Ulp1 can process the SUMO precursor 
(Hickey et al. 2012). Both are cysteine proteases that contain a papain-like fold 
and operate using a conserved -200 residue core domain (Ulp1 domain, or UD) 
that houses a catalytic cysteine residue. Ulp1 is necessary for viability owing to 
its ability to process precursor SUMO (Li & Hochstrasser 1999; Li & Hochstrasser 
2000; Strunnikov et al. 2001). Ulp2 is non-essential but contributesto 
chromosome stability owing to its involvement in recombination repair, 
centromere cohesion and spindle formation (Lee et al. 2011; Schwartz et al.
2007; Baldwin et al. 2009). A third potential SUMO protease has recently been 
uncovered. The metalloprotease known as Wss1 displays weak SUMO- 
dependent isopeptidase activity in vitro. Interestingly, Wss1 also has 
deubiquitylating activity and shows a preference for cleaving ubiquitin from
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SUMO chains. This activity, along with a newly discovered physical interaction 
with the proteasome, have suggested that Wss1 acts on sumoylated substrates 
entering the proteasome (Mullen, Chen, and Brill 2010).
Loss of Ulp1 mediated deconjugation results in cells arresting with large 
buds, presumably late in the cell division cycle (Li & Hochstrasser 1999; Hickey 
et al. 2012). Conversely, loss of Ulp2 is tolerated, but cells display sensitivity 
towards DNA damage and heat stress along with defects in meiosis (Hickey et al. 
2012). Additionally, cells expressing a temperature-sensitive mutant of Ulp1 build 
up Clb2, a B-type cyclin that promotes the transition from G2 to M phase and is 
targeted for destruction after mitosis(Kerscher, O.; unpublished observation). To 
date, no substrates of Ulp1 involved in cell cycle progression have been 
identified.
Roles for SUMO
Sumoylation plays diverse roles in a wide range of cellular functions. In 
broad terms, attachment of SUMO may do one of three things. Firstly, 
sumoylation can obscure interaction domains of its conjugate and act as an 
antagonist to other substrates binding. For example, in yeast, the proliferating 
cell nuclear antigen (PCNA) undergoes sumoylation during S-phase. This 
sumoylation event occurs predominantly on lysine 164; a residue which can 
undergo both mono- and poly-ubiquitylation as well. Sumoylation on K164 
obscures the residue from the ubiquitylation machinery and, in doing so, prevents 
PCNA-dependent DNA repair (Pfander et al. 2005; Hoege et al. 2002). Secondly,
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sumoylation can lead to conformational changes in conjugate proteins, exposing 
or hiding key interaction domains within the target. For example, in humans, 
thymine DNA glycosylase (TDG) initiates base excision repair by removing 
thymine from sites of nucleotide mismatch, generating an abasic site. SUMO 
conjugation to TDG induces a conformational change which promotes TDG 
dissociation from the abasic site (Steinacher & Schar 2005; Baba et al. 2005). 
Thirdly, sumoylation can recruit interacting partners to conjugate protein. 
Recruitment of novel interacting partners can be done by creation of a new 
interaction domain at the SUMO interface or by direct non-covalent interactions 
with attached SUMO. As an example, the yeast SUMO-Targeted Ubiquitin Ligase 
(STUbL) complex Rad18 interacts specifically with sumoylated PCNA using 
SUMO-interacting motifs (SIMs) near the amino-terminus of the ligase. This 
SUMO facilitated interaction stimulates mono-ubiquitylation of PCNA in response 
to DNA damage (Parker & Ulrich 2012). Sumoylation is required for viability and 
changes made to a protein by sumoylation have broad biological importance. To 
date, the yeast SUMO proteome consists of more than 500 proteins effecting 15 
major biological pathways (Tan et al. 2013). However, the function of only a 
handful of sumoylated proteins is known.
Chains of SUMO and Ubiquitin
One hallmark of modification by SUMO and ubiquitin is the ability of these 
Ubls to form chains. Both SUMO and ubiquitin present internal lysine residues 
that can be used to assemble polymeric chains. Poly-modifier chains can be 
linear when linked to the same residue uniformly, or branched chains can form
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when multiple lysines are used. Assembly and disassembly of chains are carried 
out using the same enzymatic machinery as single-moiety modification (model 
1 previewed by Ulrich 2008; Kerscher et al. 2006)
For ubiquitin, seven internal lysines as well as the N-terminus are targets 
for polyubiquitylation(Finley et al. 2012). The most prominent function of 
polyubiquitylation is the initiation of protein degradation; polyubiquitylation by K48 
linked ubiquitin chains directs conjugated proteins to the proteasome (Chau et al. 
1989). Research into the roles of ubiquitin chain formation is ongoing, but distinct 
outcomes for polyubiquitylation have been identified. For example, 
polyubiquitylation by K63 linked ubiquitin chains activates kinases in the NF-kB 
pathway leading to NF-kB activation (Chen 2005). Ubiquitin is an information rich 
molecule, and construction of distinct chains results in a “ubiquitin code”; a 
structure of ubiquitin molecules readable by a large family of ubiquitin receptors 
(Finley et al. 2012; Randles & Walters 2012).
In contrast to ubiquitin chains, relatively little is known about the function 
of poly-sumoylation. Yeast SUMO contains consensus SUMO attachment sites 
at K11, K15, and K19 which act as acceptors for SUMO polymerization (Ulrich 
2008). Current reasoning suggests that poly-sumoylation creates additional 
binding surfaces on the modified target allowing for more robust non-covalent 
interactions of an effector protein containing SUMO-interacting motifs (SIMs) 
(Ulrich 2008). For example, the promyelocytic leukemia protein (PML) is a poly- 
sumoylated protein which also contains a SIM in its C-terminus. Poly-sumoylation
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of PML promotes nucleation of PML and assembly into nuclear bodies (NBs) 
through SUMO-SIM interactions (Kerscher 2007; Gao et al. 2008).
SUMO-mediated interactions
SIMs arenoncovalent SUMO-binding elements within SUMO-interacting 
proteins. SIMs allow SIM-containing proteins to interact with their sumoylated 
binding partners. One SIM has been described so far which has a loose core 
consensus motif (V/l-X-V/l-V/l) (Song et al. 2004). This hydrophobic core takes 
on an extended conformation that embeds within a hydrophobic surface 
depression of SUMO. Flanking acidic residues can orient the binding of SIM to 
SUMO (Kerscher 2007; Hochstrasser 2009). Additionally, phosphorylation 
juxtaposed to the hydrophobic core can increase the number of charges and 
facilitate SUMO interaction (Stehmeier & Muller 2009).
Historically, SUMO has been proposed to antagonize ubiquitin conjugation 
on common substrates (Desterro et al. 1998). Recent evidence, however, 
revealed cross-talk between the ubiquitin and SUMO systems. Evidence is 
accumulating that SUMO chains can be sequentially modified by ubiquitin, 
forming hybrid SUMO-ubiquitin (ub) chains(Mullen & Brill 2008; Sun et al. 2007; 
Guzzo et al. 2012). Construction of these hybrid SUMO-ub chains is carried out 
by a newly defined group of enzymes known as SUMO-Targeted Ubiquitin 
Ligases (STUbLs) (Mullen & Brill 2008; Xie et al. 2007). STUbLs mediate hybrid 
chains’ function to direct modified proteins to the proteome and have been 
suggested to play a role in genome stability, transcriptional regulation, and DNA
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stability (reviewed by Wang & Prelich 2009; Heideker et al. 2009). Adding to the 
complexity, emerging research has identified enzymes that recognize hybrid 
chains using a tandem SUMO- and Ubiquitin (tSIM-UlM) interacting motif (Guzzo 
& Matunis 2013). Tandem SIM-UIM containing proteins act on substrates 
previously targeted by STUbLs. For example, the BRCA1 -A subunit RAP80 is a 
DNA repair factor and the first described tSIM-UlM containing protein. RAP80 
interacts with ~80-fold higher affinity to hybrid SUMO-Ub chains in comparison to 
monomorphic SUMO or ubiquitin chains (Guzzo et al. 2012).
SUMO-Tarqeted Ubiquitin Ligases
STUbLs have been identified in multiple organisms and the STUbL family 
currently consists of: Human RNF4; Schizosaccharomycespombe Rfp1, Rfp2 
and Slx8; Dictyosteliumdiscoideum Mip1; Drosophila me/anogasterdegringolade; 
and Saccharomyces cerevisiae Slx5-Slx8, Rad18, and potentially Uls1 (Sun et al. 
2007; Parker & Ulrich 2012; Denuc & Marfany 2010; Alonso et al. 2012). To date, 
all known STUbLs share an N-terminal SUMO recognition region (with multiple 
SIMs) used in target identification as well as a C-terminal RING finger domain 
(Denuc & Marfany 2010). STUbLs are evolutionary conserved and 
STUbLorthologs from other species can complement yeast STUbL mutants 
(Kosoy et al. 2007; Sun et al. 2007; Prudden et al. 2007). The best characterized 
members of the STUbL family are human RNF4 and budding yeast Slx5-Slx8.
10
Slx5-Slx8: A Yeast SUMO-Tarqeted Ubiquitin Ligase
Slx5 is one of the founding members of the STUbL class of enzymes. 
Originally identified in a synthetic lethal screen of cells lacking Sgs1, it functions 
as a heterodimer with Slx8 harboring RING-dependent ligase activity, and SIM 
containing Slx5 primarily responsible for SUMO recognition (Mullen et al. 2001).
Slx5-Slx8 controls the levels of cellular sumoylated proteins and high- 
molecular weight SUMO chains and is required for genome stability and DNA 
damage response (Uzunova et al. 2007; Zhang et al. 2006; Xie et al. 2007). Slx5 
and Slx8 reside in the nucleus and Slx5 also forms distinct foci and localizes to 
sites of double stranded DNA breaks (Cook et al. 2009; Nagai et al. 2008). Loss 
of Slx5-Slx8 function leads to gross chromosomal rearrangements, spontaneous 
DNA damage, and sensitivity to genotoxic stress (Nagai et al. 2011; Heideker et 
al. 2009). Slx5-Slx8 appears to direct SUMO-conjugated proteins to the 
proteasome by mediating ubiquitylation (Uzunova et al. 2007; Mullen & Brill 
2008). Consistent with this role, overexpression of Slx5 (in the presence of 
conjugation-competent SUMO) suppresses the lethality of ulp lts  cells (Xie et al.
2007).
Known substrates of Slx5-Slx8 include the transcriptional regulator Mot1, 
which regulates the DNA binding ability of TATA-binding protein, as well as the 
mating type transcription co-activators MATal and MATa2 that regulate 
transcription from mating type-specific genes (Wang & Prelich 2009; Xie et al. 
2010; Nixon et al. 2010). Few In vivo targets of Slx5-Slx8 have been identified to
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date largely due to the difficulty in identifying E3 targets. The small overall 
population of sumoylated proteins and the transient nature of ubiquitylated 
proteins hamper substrate identification. Previous work in the Kerscher lab has 
identified the E3 SUMO ligase known as Siz1 to be a potential target for the Slx5- 
Slx8 complex. Yeast two-hybrid assays performed in the Kerscher lab by 
previous master’s student Jason Westerbeckdemonstrated a robust interaction 
between Siz1 and Slx5. Furthermore, Westerbeck and colleagues found that the 
interaction between Siz1 and Slx5 may be SUMO-dependent and requires a SIM 
located in the N-terminal domain of Slx5. They went on to show that Siz1 is an in 
vitro ubiquitylation substrate of Slx5-Slx8 (Westerbeck et al. 2013).
Aims
We hypothesize that Ulp1 desumoylates a key cell cycle regulator and 
loss of Ulp1 activity stalls the cell cycle during G2/M phase. Chapter 2 of this 
thesis describes the use of a novel substrate trapping mutant of Ulp1 created in 
the Kerscher lab by former master’s student Zac Elmore to identify and 
functionally characterize Ulp1 substrates involved in cell cycle progression 
(Elmore et al. 2011).
Chapter 3 of this thesis builds on previous data described aboveand will 
investigate the functional interplaybetween Siz1 with Slx5. Specifically,chapter 3 
will show that Slx5 affects the steady state level of Siz1. Additionally, it will 
demonstrate that Slx5 affects the phosphorylation and sumoylation status of Siz1
12
and will investigate the localization of GFP-tagged Siz1 in WT cells in 
comparison to slx5A, msn5A, and slx5A/msn5A mutant strains.
SUMO/Ub Precursor
Processing DUB orUlp
Substrate
Deconjugation
^  SubstrateSubstrate
El, E2, E3DUB orUlp
El + ATP
Conjugation
E3 Ligase
Activating Enzyme Conjugating Enzyme
Model 1. The ubiquitin and SUMO cycles. Precursor SUMO and ubiquitin (blue 
rectangle) are initially processed by DUB/Ulp isopeptidases into conjugation 
competent form. Once processed, the modifier is covalently conjugated to a lysine 
side chain of a targeted substrate (red oval) in a three enzyme cascade consisting 
of E1 activating enzyme (light blue), E2 conjugating enzyme (green) and E3 ligase 
(yellow). After conjugation, additional monomers can be added to the substrate, or 
the process can be reversed by removing the modification using a DUB or Ulp 
isopeptidase (Kerscher et al. 2006).
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Chapter2. A substrate trapping mutant of Ulp1 for the identification of 
SUMO protease targets
Elmore et al. (2011) have previously reported the ability of a 
mutated form of Ulp1 to act as a substrate-trapping mutant. In their work, a 
truncation of Ulp1 comprising only the catalytic region (region 3) of the protein (Li 
& Hochstrasser 2003) was mutated by site directed mutagenesis. By switching 
the active cysteine residue at position 580 to a serine, the authors’ generated a 
substrate-trapping mutant designated Ulp1(lll)C580S.
In this chapter we utilized the substrate-trapping mutant of U lp l’s catalytic 
domain, Ulp1(HI)C580S, to affinity purify and selectively enrich SUMO protease 
substrates. We identified 32 candid Ulp1 substrates through mass spectrometry 
analysis of U-Tag purified proteins.
Materials and Methods
Yeast strain, plasmids, bacteria and growth conditions
Yeast, plasmids, and bacterial strains used for this work are listed in table 
1. Yeast media preparation and growth conditions were carried out as previously 
described (Amberg et al. 2005). All yeast strains were grown at 30°C in 2x media 
unless noted otherwise. Cells expressing a temperature-sensitive mutant of Ulp1 
(ulp lts ) contain three mutations (1435V, N450S and I504T) in the catalytic 
domain, region 3 (Li & Hochstrasser 1999).
Recombinant protein expression and bacterial protein extraction
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Induction of U-Tag overexpression -  BOK 752 containing maltose binding 
protein fused Ulp1 (lll)C580S(Elmore et al. 2011) was inoculated into 4mL of LB 
broth containing 60pg/mL carbenicillin (USABiological) and cultured overnight, 
rotating at 37°C. This 4mL culture was added to 200mL of SOC and grown at 
37°C to OD6oo0.3-0.5. A 1mL sample was harvested, washed once in 1x PBS, 
and resuspended in 1x LDS sample buffer containing 4% 2-mercaptoethanol 
(BME) (Invitrogen). This sample was boiled at 110°C for 3 minutes and then 
frozen at -80°C. This freeze then thaw process was done a total of three times.
To the remaining culture, 80pL of 1M IPTG was added to induce MBP- 
Ulp1 (|||)C580S expression. The culture was shaken for 5 hours at 18°C. Another 
1mL sample was taken as described above. To analyze protein induction, 10pL 
and 20pL of induced protein sample were subjected to SDS-PAGE on a pre-cast 
4-12% Bis-Tris mini-gel (NuPAGE, Invitrogen). Samlples ran for 55 minutes at 
200 volts in commercial MOPS buffer (Invitrogen). Bands were analyzed by 
staining with Simply Blue SafeStain (Invitrogen) as per the manufacturer’s 
instructions.
The induced culture was harvested at 4°C for 15 minutes at 2,320x g 
(RCF). The supernatant was decanted away and residual media was removed by 
pipetting. Cell pellets were kept on ice and resuspended in 4mL of phosphate 
buffered saline (PBS) (10 mMphosphate, 150 mM sodium chloride, pH 7.4) 
containing 1x Halt Protease Inhibitor (PI) Cocktail, EDTA free (Thermo Fisher 
Scientific). These 4mL were spun down into a 2mL cryo-tube and snap frozen in 
liquid nitrogen. Pellets were kept at -80°C until use.
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Bacterial protein extraction -  Frozen induced cell pellets were thawed on 
ice and resuspended in 800pL 1x PBS containing 1x PI. Total volume was 
brought up to 2mL with 1x PBS. Cell suspensions were sonicated three times at 
20% duty cycle for 20 seconds. Resulting lysates were clarified by centrifugation 
at 20879 x g (RCF) for 8 minutes in a refrigerated centrifuge. The supernatant or 
extracted protein was removed to a pre-chilled 15mL screw cap tube and the 
volume was adjusted to 4mL total using cold 1x PBS.
Affinity resin preparation -  Gravity filtration columns were assembled as 
per the manufacturer’s instructions (Thermo Fisher Scientific). 500pL of amylose 
resin suspension (New England Biolabs) was equilibrated in ice cold 1x PBS. 
Then, equilibrated amylose resin was added to the column as a bed and washed 
three times with cold 1x PBS. Bacterial protein extractions (previous section) 
were added to the column to purify MBP tagged Ulp1 (lll)C580S. After three washes 
in ice cold 1x PBS, amylose resin with bound MBP tagged Ulp1(lll)C580S was 
removed from the column and stored on ice in 1mL of 1x PBS containing 0.02% 
sodium azide. Amylose bound MBP-Ulp1 (|||)C580S is hereafter referred to as ‘U- 
Tag affinity resin.’
Yeast protein extraction
A single colony of YOK 428 was grown overnight in 40mL of selective 
media containing 2% dextrose and 200pg/ml_ G418. The next day, the 40mL 
starter culture was added to two liters of selective media containing 2% dextrose 
giving an OD6oo of about 0.2. The two liter culture was split into four flasks for
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overnight growth. The third day, the logarithmically growing culture was diluted 
1:2 in YPD to an OD6oo of 0.8 and allowed to grow an additional 3 hours. The 
whole culture was harvested by centrifugation at 4,000xg for 10 minutes at 4°C. 
The pellet was washed first in 50mL wash buffer (table 2; appendix) and then in 
10mL of extrusion buffer (table 2; appendix). Residual buffer was removed by 
micropipettor and the cell paste was scooped into a 10mL syringe with a sterile 
spatula. The cells were then extruded from the syringe into a 50mL centrifuge 
containing liquid nitrogen and snap-frozen as high density ‘noodles’ of cells.
Snap frozen cell noodles were added to a pre-cooled (-20°C) coffee 
grinder (Biospec Products) containing pre-powdered dry ice (enough to cover 
cells). The grinder was run for 5 minutes at -20°C to pulverize the cells. The 
resulting powder was placed at -80°C until the remaining dry ice is sublimated. 
Pulverized cell powder was resuspended in 20mL of extraction buffer + PI (table 
2; appendix) then snap frozen.
U-Taq affinity chromatography
500pL of U-Tag affinity resin (preparation described above) was 
equilibrated in extraction buffer by washing 3 times with 1ml_ each. Equilibrated 
U-Tag resin was transferred to a gravity filtration column (Thermo Fisher 
Scientific), washed two additional times with one column volume of extraction 
buffer, and kept at 4°C.
Frozen yeast protein extract (described above) was thawed on ice. A 30pL 
aliquot was taken, mixed with an equal volume of 2x LDS sample buffer + 8%
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BME (Invitrogen), and used as whole-cell extract in subsequent protein analysis 
(supplemental figure 6). To the chilled affinity column, 7.5mL of yeast protein 
extract was gravity filtered through the resin bed. The resin bed was then washed 
with three column volumes of extraction buffer + PI (table 2; appendix) containing 
1% triton x-100. The substrate-bound U-Tag resin was transferred to a 
microcentrifuge tube and a 30pL sample was taken for subsequent protein 
analysis.
Proteins bound to U-Tag affinity resin were eluted from the resin using 
commercially available recombinant Ulp1-His6 (Invitrogen) to cleave captured 
substrates from the U-Tag. Cleavage and purification were carried out as per the 
manufacturer’s instructions. Briefly, substrate-bound U-Tag resin was collected 
by gentle centrifugation (5 seconds, 60 x g(RCF)) and resuspended in 200pl of 
the supplied 1x SUMO protease buffer. 10 units of SUMO protease were added. 
The tube was mixed gently and the reaction was incubated at 30°C for 6 hours. 
After incubation, the supernatant was collected and purified using a commercial 
PrepEase (affymetrix) Histidine-Tagged protein purification kit to remove Ulp1- 
His6. Column flow through containing SUMO conjugates and free SUMO were 
used in subsequent protein analysis.
Silver stain and mass spectrometry
Protein concentration of the purified SUMO conjugates solution (above 
section) was measure using commercial BCA assay kit (Sigma) as per the 
manufacturer’s protocol. Then, 50ng of total protein were separated on a precast
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4-12% Bis-Tris mini-gel (NuPAGE, Invitrogen) for 55 minutes at 200 volts in 1x 
MOPS buffer. Protein bands were visualized in the gel using a commercial Pierce 
silver staining kit for mass spectrometry (Thermo Fisher Scientific) as per the 
manufacturer’s instructions.
The remaining solution of purified SUMO conjugates (~150pg) was sent to 
the Yale proteomics facility (Keck Biotechnology Resource Laboratory) for mass 
spectrometry analysis.
Results
Considering the important role of SUMO deconjugation to SUMO 
homeostasis, we sought to identify novel targets of Ulp1. Furthermore, given the 
essential nature of Ulp1 to the cell cycle, we reasoned that one or more proteins 
that co-purify with Ulp1(lll)C580Swould be Ulp1 targets that are critically important 
for cell cycle progression. Here we report the use of Elmore and colleagues’ 
substrate-trapping mutant, known as U-Tag, to selectively purify Ulp1- 
interactingproteins(Elmore et al. 2011).
U-Tag affinity purifies sumoylated proteins from whole cell extracts
Cellular extracts fromu lp lts  mutantYOK428 were subjected to U-Tag 
affinity purification (supplemental figure 6).Fifty nanogramsof purified protein and 
an equal volume of mock purificationeluate were separated by SDS-PAGE and 
visualized with silver stainingto identify protein bands. Several distinct bands
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were observed in the sample lane (figure 1. Lane 2) and were not present in the 
mock column control lane(figure 1. Lane 3) suggesting that these bands are U- 
Tag co-purifying proteins. Notably, we identified asingle band at about 20kDa 
consistent with monomeric SUMO that was liberated from its substrate by 
recombinant Ulp1 (see methods; elution step). Several additional robust bands 
representing U-Tag purified proteins are indicated by arrows in figure 1.
Mass spectrometry analysis identifies 32 U-Tag co-purifying proteins
In order to identifyU-Tag affinity purified proteins,mass spectrometry 
analysis was carried out by the Yale Proteomics facility (W.M. Keck 
Biotechnology Laboratory; New Haven, CT). Multiple dimension protein 
identification technique (MudPIT) was used to identify and sequence 69 peptide 
fragments belonging to 32 distinct proteins (table 3; appendix). Proteins 
represented by multiple fragments were present in relatively high concentration. 
Eight candidate sumoylated proteins were identified with more than three 
fragments; BMH1, SMT3, EF2 (ETF2), HSP82, KPYK1 (CDC19), PHSG (GPH1), 
RLAO (RPPO), and VATE (VMA4) [table3; parentheses represent gene names 
from Saccharomyces Genome Database]. In table 4, we have highlighted BMH1, 
VATE, and EF2 as candidates for future investigation as well as yeast SUMO 
which is our internal control. Vma4, Ef2, and Bmh1 were all previously identified 
as a sumoylated proteins in high-throughput proteomic studies (Denison et al. 
2005; Sung et al. 2013). Bmh1 is of particular interest to us given the many 
regulatory functions of 14-3-3 proteins and its association with the anaphase 
promoting complex.
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In summary, our data confirm that the U-Tag can effectively purify and 
enrich sumoylated proteins. Additionally, we have identified several candidate 
Ulp1 substrates including one regulator of the anaphase promoting complex.
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Figure 1. U-Tag affinity resin selectively purifies sumoylated proteins from 
cellular extracts. Sumoylated proteins from YOK 428 were U-Tag affinity purified 
and eluted as described in Methods. 50ng of U-Tag purified proteins were loaded in 
lane 2 and an equal volume of mock eluate in lane 3. Lane 1 contains a molecular 
weight standard and lane 4 contains whole cell protein extraction (WCE) as a 
control for protein separation. Input proteins were run on a 4-12% Bis-Tris gel and 
Silver stained with Pierce silver staining kit for mass spectrometry (Thermo 
Scientific). Arrows indicate positions of select bands present in U-Tag lane but not 
in mock column control lane. Numbers indicate approximate molecular weight (left) 
and lane designation (bottom).
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Discussion
This chapter reveals that the substrate-trapping mutant of UlpVs catalytic 
domain, Ulp1(lll)C580S(Elmore et al. 2011), can be employed to affinity purify, 
selectively enrich, and identify candidate Ulp1 substrates. One interesting 
observation made from this screen for U-Tag interacting proteins is that Bmh1 
carries the potential to be a Ulp1 substrate. Bmh1 is one of two proteins in 
Saccharomyces cerevisiae that represent the highly conserved 14-3-3 family of 
proteins. Previous proteomic studies have shown Bmh1 to be sumoylated 
(Denison et al. 2005) and revealed many putative interacting partners. Recent 
work in the Kerscher lab by Jeremy Wells (WM class of 2014) has confirmed 
Bmh1 sumoylation biochemically in a molecular weight shift assay,but the exact 
cellular consequences of Bmh1 sumoylation are unknown. Bmh1 has recently 
been shown to be a regulator of the cell cycle (Dial et al. 2007). Bmh1, in 
complex with the pseudosubstrate inhibitor Acm1, binds to a co-activator of the 
Anaphase-promoting complex (APC) known as Cdh1. This interaction sequesters 
Cdh1 and inactivates the APC; an event necessary for cell cycle progression 
through S-phase (Dial et al. 2007).
We propose that SUMO may play a role in Bmh1 ’s cooperative regulation 
of the APC and that interactions with Ulp1 regulate its sumoylation (model 2). 
Specifically, we propose that sumoylation of Bmh1 facilitates the interaction 
between Bmh1/Acm1/Cdh1 (CAB complex) and mediates APC deactivation at 
the onset of S-phase. Furthermore, we hypothesize that Ulp1 mediates
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desumoylation of Bmh1 after G2, which initiates the dissociation of the CAB 
complex and reactivates the APCCdh1. This hypothesis is supported by previous 
findings that u lp lts  cells grown at non-permissive temperatures arrest as large 
budded cells, presumably late in the cell cycle. This late-stage arrest could be 
caused by a failure of Ulp1 to desumoylate cell cycle regulators, such as Bmh1. 
Additionally, strains expressing ulp lts  have artificially stabilized Clb2 levels. Clb2 
is a B-type cyclin and APC substrate that promotes transition from G2 to M 
phase in yeast cells. Clb2 is targeted for destruction via a destruction box motif 
during G1 when the CAB complex is dissociated and the APCcdh1 is active. This 
buildup of Clb2 could be due to reduced APC activity and prolonged 
sequestration of CDH1 in the CAB complex, potentially because Ulp1 fails to 
desumoylate Bmh1.
To this end, our future work will investigate the consequences of Bmh1 
sumoylation. Using a SUMO deficient mutant of Bmh1 Ulp1 created in the 
Kerscher lab by Jeremy Wells (Bmh1 sumo-no-more or SMN; figure 2) we will 
conduct a top-down investigation of the role of Bmh1-SUMO on the cell division 
cycle. We will use a bmh1 Abmh2Adoub\e mutant strain expressing either wild- 
type Bmh1 or Bmh1 (SNM) from a plasmid to look for growth defects incurred 
from loss of Bmh1 sumoylation. Preliminary experiments performed in the 
Kerscher lab by Jeremy Wells have revealed a temperature sensitive phenotype 
associated with deficient Bmh1 sumoylation.
Next, we will verify Bmh1-SUMO as a U-Tag interacting protein and a 
Ulp1 substrate in vivo. By co-expressing affinity tagged Ulp1(lll)C580S and epitope
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tagged Bmh1 we will pull downUlp1(lll)C580S and co-purify sumoylated Bmh1 from 
yeast extracts. From there, we will express tagged Bmh1 in aulp 1 ts strain 
coexpressing conjugation competent SUMO to show that desumoylation of Bmh1 
is abolished at non-permissive temperatures.
Finally, we plan to investigate the molecular consequences of Bmh1 
sumoylation. Again, using the SUMO-deficient mutant we will determine what, if 
any, role sumoylation plays in the regulation of APC0dh1 activity. Specifically, we 
will determine if CAB complex formation and dissociation is facilitated by Bmh1- 
SUMO dynamics.
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Model 2. Proposed role for SUMO dynamics in regulation o f APCCdh1 activity.
Sumoylation of Bmhl during late G1 (bottom arrow) facilitates the association of 
Bmhl, Acm1, and the APC co-activator Cdh1 (CAB complex) (Dial et al. 2007). 
Sequestration of Cdh1 in the CAB complex throughout S-phase and G2 maintains 
the APC in an inactive state. Ulp1 mediated desumoylation of Bmhl in late G2 or 
early M phase (top arrow) causes dissociation of the CAB complex and APCCdh1 
reactivation. The APCCdh1 then triggers mitotic exit through degradation of the 
cyclin Clb2.
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SUMO-no-more mutant was constructed by Jeremy Wells (WM class of 2014) 
mutating six high probability lysine residues into arginine. Colored residues on 
the right represent mutated amino acids. SUMOplot™ Analysis Program 
(http://www.abgent.com/sumoplot.html
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Chapter 3. A SUMO-targeted ubiquitin ligase is involved in the cell cycle- 
specific degradation of the SUMO E3 ligase Siz1
Chapter 3 builds on previous data collected by Jason Westerback 
described above and reported in the Kerscher lab’s most recent publication 
(Westerbeck 2011). This chapter reports our findings on the functional interplay 
between Siz1 with Slx5. Specifically; the data presented here shows that Slx5 
affects the steady state level of Siz1. Additionally, it demonstrates that Slx5 
influences the phosphorylation and sumoylation status of Siz1. Finally, this 
chapter reports the localization of GFP-tagged Siz1 in WT cells in comparison to 
sfx5A, msn5A, and slx5A/msn5A mutant strains.
Materials and Methods
Yeast strains. Media and Plasmids
Yeast strains and plasmids used in this study are listed in Table 1.
Unless otherwise noted, yeast media preparation and manipulation of yeast 
cells was performed as previously reported (Guthrie and Fink, 2002). All 
strains were grown at 30°C unless otherwise noted.
Cell synchronization and drug treatments
Where indicated yeast cells were synchronized in G2/M phase by
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incubating logarithmically grown cells in 15 pg/ml nocodazole (Acros 
Organics 358240500) for 3 hrs at 30°C. Cells were arrested in S-phase by 
addition of 0.1 M hydroxyurea (Sigma H8627) and incubation at 30°C for 3 
hours. For cycloheximide chase experiments, 25 pg/ml cycloheximide (Sigma 
C7698) was added to G2/M arrested cells. 2.5 ODs of cells were harvested at 
the indicated time-points.
Cloning and epitope-tagging of yeast genes
Chromosomal tagging and gene deletions in yeast were carried out by 
PCR-based homologous recombination (Longtine etal., 1998). Strain 
YOK821 (slx5A) was used to epitope tag SIZ1 with a 13myc epitope tag. 
Briefly, primers OOK663 and OOK662 were used to amplify the 13xmyc- 
ADH1-His3MX6 cassette with 40bp of SIZ1 sequence homology from the 
plasmid pFA6a-13myc-His3MX6 (Longtine). PCR amplification was carried 
out using Phusion High-Fidelity PCR kit (NEB E0553S) with DMSO and high 
GC buffer as recommended by the manufacturer. For transformation, 6.5 pg 
of purified SIZ1-13myc-His3MX6 PCR product was combined with 4 ODs of 
competent s/x5A (YOK821) cells, incubated for 30 minutes at 30°C, heat 
shocked at 42°C for 30 minutes and plated on SD-His dropout. Resulting 
colonies were screened by western blotting using an anti-myc antibody. 
Subsequently, the SIZ1-myc slx5A strain (YOK2264) was backcrossed to 
YOK819 to obtain StZ1-myc SLX5(WT) progeny (YOK2286). An amplicon of 
SIZ1-13myc was also cloned into a gateway compatible pRS315 plasmid.
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The msn5 null mutant was constructed in the Kerscher lab by Nagesh 
Parsupala. who introduced a Hygromycin deletion cassette with 78 bp 
flanking sequence homology to msn5 gene upstream and downstream 
region.
Preparation of yeast extracts, gel electrophoresis, and western blotting
Whole cell yeast extracts were prepared by TCA glass bead lysis. Briefly, 
-  4 ODs of pelleted yeast cells were washed once in 800 pi of 20% TCA and 
resuspended in 400 pi of 20% TCA. 200 pi of glass beads (Sigma G8772) 
were added and the samples were vortexed at 4°C for 4 minutes. The beads 
were allowed to settle and the supernatant was transferred to a new tube and 
pelleted by centrifugation at 15K rpm for 8 minutes. Pellets were washed 
once using 800 pi of ice-cold 2% TCA. The supernatant was removed and 
pellets were resuspended in 200 pi of TCA-sample buffer (15% glycerol, 80 
mM Tris base, 3.5% SDS, Bromophenol Blue, and BME [40 pl/ml]). The 
samples were boiled at 100°C for 2 minutes, and whole cell protein extracts 
corresponding to -  0.2 ODs were separated on a pre-cast NuPAGE Novex 4- 
12% Bis-Tris gels (NP0321 Life Technologies) or home-made 8% Tris-Glycine 
gels. After separation proteins were transferred to polyvinylidene difluoride 
(PVDF) membrane (IPVH00010 - Millipore) for 30 minutes at 19 V. Blots were 
blocked in TBS (150 mM NaCI, 50 mM Tris-HCI at pH 7.4) containing 4% milk 
for an hour and then incubated in 4% milk containing primary antibody 
overnight at 4°C followed by incubation with secondary antibodies for 1-3
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hours at ambient temperature. After antibody incubations blots were 
extensively washed in TBS + 0.1% Tween 20 (TBST). Antibodies were used at 
the following concentrations; anti-myc (1:5000; Covance MMS-150R), anti- 
Pgk (1:10000; Life Technologies A6457), anti-mouse(HRP) (1:15,000; abeam 
ab9740). Proteins were visualized on film using ECL substrate (Millipore 
Immobilon Western ECL substrate WBKL SO 100).
Fluorescent Microscopy
Images of live cells were collected using a Zeiss Axioskop fitted with a 
Retiga SRV camera (Q-imaging), i-Vision software (BioVision Technologies), 
and a Uniblitz shutter assembly (Rochester, NY). Pertinent filter for the above 
application was CZ909 (GFP) (Chroma Technology Group). Where 
applicable, images were normalized using i-Vision software.
Results
Slx5 affects the steady-state level, phosphorylation, and sumoylation of 
Siz1 in vivo
In order to understand the role of Slx5 in Siz1 stability, we compared 
endogenous Siz1 levels from wild-type (WT) and slx5 null (A) strains. Briefly, 
YOK 2264 containing 13X Myc-tagged Siz1 was mated with isogenic WT strain 
YOK 819. In meiotic progeny expressing Myc-tagged Siz1, immuno-blotting 
detected the protein running as a distinct band just below the 150kDa marker
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(Figure 3A). Intriguingly, an increased level of high molecular weight adducts of 
Siz1 were also observed in slx5A cells. These slower moving abducts are 
consistent with sumoylated forms Siz1.
Siz1 is located in the nucleus during interphase, but is exported to the 
cytoplasm during mitosis. As mentioned above, cytosolic Siz1 enriches at the 
bud neck of dividing yeast cells where it sumoylates the septin proteins Cdc3, 
Cdc11, and Shs1 (Johnson and Gupta, 2001). Nuclear egress of Siz1 is 
mediated by the karyopherin Msn5 which is known to export phosphorylated 
proteins (Makhnevych et al., 2007). At a point prior to anaphase, Siz1 becomes 
phosphorylated by an unknown kinase, which may be linked to its export by 
Msn5 (Johnson and Gupta, 2001). We investigated the phosphorylation status of 
Siz1 by comparing both WT and slx5A cells growing logarithmically, arrested in
S-phase with hydroxyurea (HU), and arrested in G2/M with nocodazole (N2) 
(Figure 3B). The levels of unmodified Siz1 as well as two phosphorylated forms 
were markedly enhanced in slx5A cells. The effect was less pronounced after S- 
phase and G2/M arrest with almost complete phosphorylation of Siz1 in G2/M 
arrested cells. Phosphorylation was confirmed by phos-tag SDS-PAGE (Wako 
Pure Chemical Industries) and immune-blotting (Parsupala, N., 2013; data not 
shown).
Slx5 is required to modulate the levels of Siz1 in the nucleus during mitosis
As shown in Figure 3, Slx5 influences the steady state level of Siz1 by an 
undetermined mechanism. This increase in steady state is coupled with an
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increase in sumoylated abducts of Siz1. Given the historic role of ubiquitylation in 
protein turnover, as well as the specificity of STUbLs for sumoylated proteins, we 
believe that Slx5 mediated ubiquitylation tags Siz1 for degradation. In order to 
test this hypothesis we conducted a series of stability assays comparing the half- 
life of Siz1 from WT and slx5d cells. To our surprise, we were unable to detect a 
change in Siz1 turnover when assaying the whole cellular pool of Siz1 (data not 
shown).
As discussed previously, Slx5 resides in the nucleus while Siz1 
localization is dynamic and cell cycle-dependent. As a result, we reasoned that 
Slx5 could be modulating the degradation of a nuclear subpopulation of Siz1 that 
is not detectable when immune-blotting the whole cellular pool of Siz1.
Therefore, we have devised a strategy that examines the interaction between 
Slx5 and nuclear Siz1. By mutating MSN5 we were able to block the nuclear 
egress of Siz1 during mitosis thereby enriching nuclear targets of Slx5. Using this 
model, we first observed GFP-tagged Siz1 in wild type cells and compared it to 
slx5A, msn5A and the msn5Aslx5A double mutant in logarithmically growing and 
G2/M-arrested cells. Consistent with previous results (Makhnevych etal., 2007), 
Siz1 -GFP resides in the nucleus for most of the cell cycle, but re-localizes to the 
septin ring during mitosis (Figure 4A). However, in both the msn5A and the 
msn5Aslx5A double mutant, Siz1 was retained in the nucleus during mitosis and 
could not be detected at the septin ring (Figure 4A).
Next we investigated the effect of Msn5 on the steady state level and 
phosphorylation state of Siz1. We compared a 4 mutant panel of WT, slx5A,
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msn5A and msn5Aslx5A strains expressing Myc-tagged Siz1 in logarithmic 
growth and G2/M arrest. In comparison to WT, no reduction in steady state level 
of Siz1 was detected in msn5A cells; however, we did observe an increase in 
steady state from logarithmically growing slx5A cells consistent with figure 3. The 
phosphorylation state of Siz1 was dramatically influenced by SLX5, MSN5, and 
cell cycle stage (Figure 5). In comparison to WT, mutating msn5A reduced the 
phosphorylation state and abolished the doubly phosphorylated adduct of Siz1 
running at the highest molecular weight. In contrast, mutating slx5A in both the 
single and double mutants increases the level of Siz1 phosphorylation. Similar to 
Figure 3, G2/M arrest equalizes phosphorylation state and levels of Siz1 in WT, 
slx5A and msn5Aslx5A strains. Intriguingly, the phosphorylation of Siz1 from 
msn5A cells remains reduced during mitosis arrest implying that some degree of 
Siz1 phosphorylation is linked to nuclear export.
In order to demonstrate that nuclear accumulation of Siz1 leads to its 
degradation, we performed a cycloheximide chase of Siz1 in mitotically arrested 
WT and msn5A cells (Parsupala, N., 2013; Figure 4B). As predicted, we found 
that the half-life of Siz1 was dramatically reduced in the msn5A strain. In 
comparison, Siz1 was only slightly modulated in the WT strain. Finally, to show 
that Slx5 contributes to Siz1 stability, we performed a cycloheximide chase of 
nuclear retained Siz1 in msn5A and msn5Aslx5A strains (Figure 4C). Consistent 
with our prediction, Siz1 was stabilized in the slx5Amsn5A double mutant, but 
degraded rapidly in the msn5A mutant. Furthermore, sumoylated adducts of Siz1 
accumulated in the double mutant, while all forms of Siz1 were unstable in the
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msn5A mutant. This effect was specific to Siz1 retained in the nucleus during 
mitosis as a similar experiment conducted in S-phase arrest showed no change 
in Siz1 stability or sumoylation (Figure 6).
In conclusion, our data reveals for the first time the functional interplay 
between SUMO E3 ligases and SUMO-targeted ubiquitin ligases and 
demonstrates that at least three post-translational modifications 
(phosphorylation, sumoylation, and ubiquitylation) are involved in this process. 
This Slx5-dependent regulation of nuclear localized Siz1 may work in 
cooperation with other pathways to prevent the accumulation of specific nuclear 
SUMO conjugates that interfere with cell cycle progression or other vital 
processes (Figure 4D).
Discussion
In this chapter we present new data on the regulation of the E3 SUMO 
ligase Siz1 by the SUMO-targeted ubiquitin ligase Slx5. Siz1 resides in the 
nucleus throughout interphase, but becomes phosphorylated in G2/M concurrent 
with its nuclear export (Johnson and Gupta, 2001). Recent work by Makhnevych 
et al, (2007) has shown that Siz1 is exported from the nucleus by the karyopherin 
Msn5 during mitosis where it enriches at the bud neck and participates in septin 
sumoylation. In addition to mitotic phosphorylation, Siz1 is modified by SUMO 
chains in vivo (Takahashi and Kikuchi, 2005). Previous studies in our lab have 
identified a physical interaction between sumoylated Siz1 and Slx5 as well as 
identified Siz1 as a STUbL substrate in vivo (Westerbeck et al., 2013). Building
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upon this work, this chapter explores the functional role of Slx5 mediated 
ubiquitylation and sheds light on the fate of nuclear Siz1 during mitosis. Our data 
raises the possibility of tripartite regulation of Siz1 involving phosphorylation, 
sumoylation, and Slx5-mediated ubiquitylation. Specifically, I found that both 
phosphorylated and sumoylated Siz1 accumulate in slx5A mutant cells (Figures 3 
and 5). When Siz1 is retained in the nucleus of an msn5A mutant, 
phosphorylated and sumoylated species are rapidly degraded (Figure 4B). In an 
msn5Aslx5A double mutant, however, phosphorylated and sumoylated Siz1 are 
stabilized in G2/M, suggesting that STUbLs play a role in modulating SUMO E3 
ligases in the nucleus (Figure 4C)
The cross-talk between phosphorylation and sumoylation is poorly 
understood; however, a link between sumoylation and phosphorylation has 
previously been established. The Siz1 ortholog PIAS1 contains a phospho- 
regulated SIM which is required to modulate its interactions with specific 
transcription factors (Stehmeier and Muller, 2009). Siz1 contains a bona fide 
SIM but we have not determined whether it constitutes a phospho-regulated SIM 
(Uzunova et al., 2007). It would be beneficial to determine how phosphorylation 
and sumoylation work together in governing Siz1 interactions, but our current 
understanding of Siz1 phosphorylation is in its infancy and many aspects of Siz1 
modification remain unclear. Future research in the lab will identify both the 
modifying kinase and phosphorylation sites in order to expand upon research 
initiated with this chapter and further characterize the complex cross-talk of 
modifications that regulate Siz1.
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In addition to describing the interplay between phosphorylation, 
sumoylation, and STUbL mediated ubiquitylation, this work begins to decode the 
link between Siz1 phosphorylation and its nuclear shuttling. Msn5 is known to 
export phosphorylated cargoes, but it is currently unknown whether or not Siz1 
export depends upon phosphorylation (Takahashi etai ,  2008; Makhnevych et 
al., 2007). Our data shows that Msn5 can itself influence phosphorylation of Siz1. 
Specifically, mutating Msn5 abolishes a slow moving phosphorylated adduct we 
believe to be a doubly phosphorylated species of Siz1 (Figure 5). From this 
preliminary data, we could speculate that a phosphorylation event regulated by 
Msn5 facilitates Siz1 export during mitosis. Alternatively, this second phosphate 
addition could be acquired in the cytosol after export and influence Siz1 
interactions with septin proteins. Further work in this direction will explore the 
timing and regulation of Sizt nuclear shuttling in order to further our 
understanding of cytoplasmic sumoylation.
In conclusion, our data describes the first account of functional interaction 
between SUMO ligases and SUMO-targeted ubiquitin ligases. We believe that 
the cell cycle-specific degradation of Siz1 by Slx5/Slx8 plays an important 
physiological role in reducing nuclear SUMO E3 ligase activity as the cell enters 
mitosis. This process likely works in conjunction with the nuclear export pathway 
of Siz1 and may prevent the accumulation of nuclear SUMO conjugates that 
interfere with cell cycle progression. Considering that Slx5 and Siz1 are 
evolutionarily conserved proteins, we predict that the STUbL-mediated regulation 
of SUMO-E3 ligases extends to RNF4 and PIAS proteins in mammalian cells. It
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will be interesting to determine whether RNF4 affects the turn-over of 
phosphorylated and sumoylated PIAS1 in mammalian cells. This would further 
support the emerging theme of a cross-talk between phosphorylation, 
sumoylation, and ubiquitylation in SUMO-targeted degradation.
STUbL regulation of sumoylation pathway likely extends far beyond Siz1. 
Recent work by Albuquerque et al. (2013) shows an antagonistic interaction 
between Slx5 and the SUMO E3 ligase Mms21. Using quantitative mass 
spectrometry they assessed the abundance of sumoylated proteins in a wild-type 
strain in comparison to slx5A mutant strain. They found that deleting SLX5 
increased the abundance of most sumoylated proteins, with Mms21 -specific 
targets being substantially elevated. It would be interesting to determine if Slx5 
influences the degradation of Mms21 in a manner similar to Siz1. The 
antagonistic relationship between Slx5 and Mms21 fits with our finding and 
supports a role for STUbLs in regulating cellular SUMO homeostasis.
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Figure 3. Slx5 affects the steady-state level and phosphorylation 
status of Sizl. (A) Altered steady-state level of Sizl in slx5A cells. A 
heterozygous diploid SLX5/slx5A SIZ1/SIZ1-myc/HIS3 strain was 
sporulated and the resulting haploid progeny of two tetrads (tetrad 7 (YOK 
2279-2282) and tetrad 10 (YOK 2283-2286) were genotyped (WT and A). 
Proteins were extracted from the indicated haploid strains to determine the 
steady-state levels of the myc-tagged Sizl protein in WT and slx5A 
progeny. An anti- myc antibody was used to detect Sizl on immunoblots of 
SDS-PAGE separated proteins. Note the increased steady-state levels and 
modifications of Sizl in slx5A strains (tetrad 7-4 and tetrad 10-3) in 
comparison to Sizl levels in SLX5 WT strains (tetrad 7-1 and tetrad 10-4). 
Equal protein loading was confirmed by immunoblot for the housekeeping 
protein 3-phosphoglycerate kinase (PGK1). (B) Sizl is differentially 
phosphorylated under various growth conditions in WT (YOK 2286) versus 
slx5A (YOK 2264) cells. Log: untreated, logarithmically growing cells; HU: 
hydroxyurea treatment to arrest in S-phase; NZ: nocodazole treatment to 
arrest in G2/M. Endogenous, myc-tagged Sizl protein in WT and slx5A 
cells was detected after immunoblotting of SDS-PAGE separated proteins 
using an anti-myc antibody. (* and **) denotes differentially phosphorylated 
forms of S iz l.
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Figure 4. Slx5 modulates the levels of Siz1 in the nucleus. (A) WT
(YOK2738), slx5A (YOK2751), msn5A (YOK2624), and msn5Aslx5A 
(YOK2735) strains expressing Siz1- GFP as the only copy of this SUMO 
ligase were imaged during logarithmic growth (log - left panel) or after 
nocodazole induced G2/M arrest (Noc - right panel). The localization of 
Siz1-GFP at septins is indicated with yellow arrows and the localization of 
nuclei in msn5A and msn5Aslx5A strains is indicated with white arrow 
heads. (B) Siz1 is rapidly degraded in an msn5A mutant: Isogenic WT 
(YOK 2397) and msn5A (YOK 2514) strains expressing endogenous full- 
length Siz1-myc were grown overnight in YPD medium. Cells in 
logarithmically grown cultures were arrested with nocodazole. 10 ODs of 
G2/M-arrested cells were pelleted, washed and resuspended in fresh YPD 
medium without nocodazole containing 25 pg/ml of cycloheximide. 
Subsequently, protein extracts of 2.5 ODs of cells were prepared at the 
indicated time points (0, 10, 30, 60 min) prior to western blotting to detect 
Siz1-myc. (C) A deletion of SLX5 stabilizes Siz1 in an msnSA mutant: 
Isogenic msn5A and msn5Aslx5A strains expressing Siz1-myc from 
LEU2/CEN plasmid pRS315 were grown overnight in selective media. Cells 
in logarithmically grown cultures were arrested with nocodazole and 
benomyl. 22 ODs of G2/M-arrested cells were pelleted, washed and 
resuspended in fresh YPD medium without nocodazole containing 25pg/ml 
of cycloheximide. Subsequently, protein extracts of 2 ODs of cells were 
prepared at the indicated time points (0, 40, 60, 90, 120 minutes) prior to 
western blotting to detect Siz1-myc and Pgk1 proteins. The first two lanes, 
msn5A (log) and msn5Aslx5A (log), are overloaded to show SUMO adducts 
of Siz1 in these strains. (D) Model of a STUbL-dependent nuclear 
degradation pathway of sumoylated Siz1: At the onset of mitosis nuclear 
Siz1 becomes auto-sumoylated (green circles) and phosphorylated (p) via 
an unknown kinase. Phosphorylated Siz1 is then subject to Msn5- 
mediated nuclear export to facilitate septin sumoylation in the cytosol. 
Sumoylated Siz1 that remains in the nucleus as the cell enters mitosis (in 
our experiments this was accomplished through deletion of MSN5) is 
subject to STUbL- mediated ubiquitylation (circle labeled Ub) and 
degradation. Other non-STUbL- dependent pathways for the regulation of 
Siz1 activity and levels may exist.
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Figure 5. Slx5, Msn5 and cell cycle stage affect the phosphorylation 
state of Siz1. Strains 2397 (WT) 2396 (s/x5A) 2514 (msn5A) and 
25'\3{slx5A/msn5A) expressing endogenous Siz1-Myc were grown up 
overnight in YPD. Proteins were extracted from 4 ODs of Log and G2/M 
arrested cells. Phosphorylation state of SizlMyc from treated and 
untreated cells was detected on immunoblots of SDS-PAGE separated 
proteins. Two levels of phosphorylation as well as unmodified Siz1 were 
detected. (Siz1-P and P-Siz1-P) denote the two phosphorylation states of 
Siz1. Siz1 phosphorylation is decreased in msn5A versus WT cells, but 
increased when SLX5 is also deleted. Siz1 is differentially phosphorylated 
in WT versus s/x5A cells and overall phosphorylation increases during 
G2/M arrest confirming the findings from Figure 8B. Log: untreated, 
logarithmically growing cells; Nocodazole: cells treated with 25 pg/mL 
nocodazole to arrest in G2/M; WT: Wild type; A/A: s/x5A and msn5A strain 
YOK 2513
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Figure 6. Cycloheximide chase of S-Phase arrested cells. Strains YOK 
2757 (WT), 2759 (msn5A), and 2761 (slx5A/msn5A) expressing SizlMyc from 
a LEU2/CEN plasmid pRS315 were grown overnight in selective media to log 
phase. Cultures that had not reached stationary phase after overnight growth 
were arrested in S-phase with 0.1M hydroxyurea. 22 ODs of S-phase 
arrested cells were pelleted, washed and resuspended in fresh YPD medium 
without hydroxyurea containing 25pg/ml of cycloheximide. Subsequently, 
protein extracts of 2 ODs of cells were prepared at the indicated time points (0, 
30, 60, 90, 120 minutes) prior to western blotting to detect Siz1-myc. MPT; 
Minutes post-treatment with cycloheximide; WT: Wild type; -Siz1 denotes 
unmodified Siz1 and SizlMyc SUMOn denotes sumoylated forms of Siz1.
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Appendix
PCR-based gene modification; Mvc tagging Siz1 (Modified from Lonqtine et a!., 
1998)
Primes OOK662 and 663 (table 5) were used to PCR amplify 13xmyc-ADH1- 
His3MX6 cassette with 40bp of SIZ1 sequence homology from the plasmid 
pFA6a-13myc-His3MX6. Primer overhangs are homologous to 40 bases 
upstream of SIZ1 stop codon and 40 bases downstream from SIZ1 stop codon, 
but do not include the stop codon itself. 8x 50pL PCR reactions were pooled and 
extracted with phenol/chloroform/isoamyalcohol. The aqueous extract was 
ethanol precipitated and resuspended in 25ul of 1x Tris-EDTA (TE) by vortexing 
and pipetting. Transformation mixture was made by combining the 12.5ul of pure 
PCR product with 160ul of sterile 50% glycerol, 20ul of 10X TE, 20ul of 1M 
lithium acetate and 5 ul of denature herring sperm DNA (ssDNA).
5mL of YOK 821 (s/x5A) was grown overnight in YPD. In the morning, the 
stationary culture was diluted to OD6oo of 0.3 and allowed to grow for 2 
generations. 10D of the recovered culture was harvested and suspended in 
100mM lithium acetate + 1X TE then incubated at 30°C for 30 minutes.
After incubating for 30 minutes, the cells were collected by brief (5 
second) centrifugation and gently resuspended in the transformation mixture 
from above. Cells in transformation mixture were incubated at 30°C for an 
additional 30 minutes before heatshocking at 42°C for 40 minutes. A long heat 
(30-40 minutes) is critical for successful transformation. After heat shocking, the 
cells were collected by brief centrifugation and washed once in pre-warmed 2x 
YEP and resuspended in pre-warmed 2x YPD. The cells were then incubated at 
30°C, spinning for 1 hour and plated on a single selective plate. Transformant 
colonies were visible after 3 days.
Additional notes; Incubating cells overnight in 100mM lithium acetate + 1X 
TE before transformation increases efficiency. We have also had success with 
overnight recoveries in YPD after transformation and overnight growth in liquid 
selective media.
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Preparation of high cell density yeast ‘noodles’ and cryogenic cell lysis.
A single colony was grown overnight in 40mL of selective media 
containing 2% dextrose. The next day, the 40mL starter culture was added to two 
liters of selective media containing 2% dextrose and split into four 1L flasks to 
allow for sufficient aeration. The two liter culture was grown to late log phase 
and the whole culture was harvested by centrifugation at 4,000 x gravity in the 
cold. The resulting cell pellet was washed first in 50mL wash buffer (table 2) and 
then in 10mL of extrusion buffer (table 2). Residual buffer was removed by 
m icro pi petto r and the cell paste was scooped into a 10mL syringe with a sterile 
spatula. The cells were then extruded from the syringe into a 50mL centrifuge 
containing liquid nitrogen and snap-frozen as high density ‘noodles’ of cells. The 
centrifuge tube containing noodles and residual liquid nitrogen was placed at - 
80°C with holes punched in the cap to allow the nitrogen to vaporize.
Yeast noodles were lysed using a cryogenic tissue grinder (coffee grinder) 
to break open the cells. To do this, dry ice was powdered in a pre-chilled (-20°C) 
grinder. The amount of dry ice powder used is arbitrary, but was enough to take 
up about half the volume of the grinder and completely cover the yeast noodles 
when they are added. Yeast noodles were taken from the -80°C freezer and 
immediately placed into the dry ice. Cells were lysed by grinding for 5 minutes on 
the espresso setting at -20°C. The resulting powder of pulverized yeast cells and 
dry ice was placed at -80°C in a 50mL centrifuge tube with the top loose to allow 
the dry ice to sublimate. The powdered yeast cells were thawed on ice and 
resuspended in extraction buffer (table 2).
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Ulpits
0
2 Liters o f yeast expressing Smt3gg and a 
te m p e ra tu re  sensitive  m u ta n t o f U lp l  (ulplts) th a t is 
d e fic ie n t in SUMO rem ova l was co llec ted  and snap 
frozen  as h igh cell d e n s ity  'n o o d le s ' by e x tru d in g  cell 
paste  fro m  a 10m l syringe in to  liq u id  n itro ge n .
Frozen cells are co ld  lysed by g rin d in g  in d ry  ice in  a 
cryogen ic tissue  g rin d e r (p ic tu re d ). Dry ice was 
a llo w e d  to  su b lim a te  a t -80° C. D is rup ted  cell 
p o w d e r was suspended in b u ffe r  + p ro tease  
in h ib ito rs , c la r ifie d , and used as th e  in p u t fo r  
a ff in ity  p u r if ic a tio n  in  th e  next step.
U lp l(3 ) (c580S) expressed in bacte ria  was b o u n d  to  
am ylose  beads fo rm in g  a U lp l(3 ) (C580S) a f f in ity  resin 
(U-Tag). 7 .5m l o f cell e x tra c t was g ra v ity  f ilte re d  
th ro u g h  450u l o f U lp l(3)(C 580S) a ff in ity  resin.
Substrate
x  “ >P
D
Sum o con juga tes , as w e ll as free  SUMO, w ere  
lib e ra te d  fro m  th e  a ff in ity  resin by c leaving  w ith  
c a ta ly tica lly  active  U lp l-H is 6  (Inv itro ge n ). C ata ly tic  
U lp l  was th e n  rem oved  by m e ta l a ff in ity  
ch ro m a to g ra p h y  leaving p u rif ie d  SUMO and SUMO 
con jugates.
Supplemental Figure 1. Diagram of methodology used for U-Tag affinity 
purification.
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Table 1. Strains and plasmids
Name Pertinent
Genotypes
Plasmids 
or construction
Reference
MHY500
(YOK819) Mata his3-A200 leu2-3, 
112 ura3- 52lys2- 
801trp1-1gal2
Li and Hochstrasser, 
2003
MHY501
(YOK820) Mata his3-A200 leu2-3, 
112 ura3- 52lys2- 
801trp1-1 
gal2
BY4741
(YOK1322)
MATa leu2A0 m etl5A0  
ura3A0
Brachmann et 
al., 1998
JD52
(YOK2062)
MATa ura3-52 his3- 
A200 Ieu2- 3,112 
trn1-A83 lvs?-RD1
Dohmen et al., 1995
YOK428 ulp1::K 
an MX; 
u lp lts
GPD-Smt3gg-LEU2
YOK2396 slx5::KanMX4 s iz l-  
13xmyc/HIS5
YOK 2373
transformed with s iz l- 
myc/HIS5
This study
YOK2397 JD52 Siz1-13xmyc:HIS5 YOK 2062 (JD52) 
transformed with s iz l- 
myc/HIS5
This study
YOK2514 msn5::HYGSiz1- 
13xmyc:HIS5 (based 
on YOK 2397)
YOK 2397 
transformed with 
msn5::hygro
This study
YOK2513 msn5::HYG, 
slx5::KanMX4 Siz1- 
13xmyc:HIS5
YOK 2396 
transformed with 
msn5::hygro
This study
YOK3712
(MHY821)
slx5::KanMX4 Xie et al., 
2007
YOK2264 six 5A Siz1- 
13xmyc:HIS5
MHY821 transformed 
with siz1-myc/HIS5
This study
YOK2286 Siz 1-13xmyc:HIS5 MHY501 transformed 
with siz1-myc/HIS5
This study
YOK2738 JD52 Siz1-GFP/HIS5 YOK 2062 (JD52) 
transformed with Siz1- 
GFP/HIS5
This study
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Name Pertinent
Genotypes
Plasmids 
or construction
Reference
YOK2751 JD52 slx5::KanMX4 
Siz1-
GFP/HIS5
YOK 2373 (JD52) 
transformed with Siz1- 
GFP/HIS5
This study
YOK2624 JD52 msn5::HYG Siz1- 
GFP/HIS5
YOK2505 (JD52) 
transformed with Siz1- 
GFP/HIS5
This study
YOK2735 JD52 slx5::KanMX4
msn5::HYG
Siz1-GFP/HIS5
YOK2681 (JD52) 
transformed with Siz1- 
GFP/HIS5
This study
YOK2757 JD52 Siz1 -13xmyc/LEU2 
on pRS315 (BOK982)
This study
YOK2758 JD52 slx5::KanMX4 Siz1 -13xmyc/LEU2 
on pRS315 (BOK982)
This study
YOK2759 JD52 msn5::HYG Siz1-13xmyc/LEU2 
on pRS315 (BOK982)
This study
YOK2761 JD52 slx5::KanMX4 
msn5::HYG
Siz1-13xmyc/LEU2 
on pRS315 (BOK982)
This study
BOK752 *R + pMAL- 
Ulp1(lll)C580S
Elmore et al., 2011
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Table 2. Buffers used in Chapter 2.
Buffer Components
Protease Inhibitors 
added
Chapter and 
relevant reference
Wash
buffer
50mM HEPES 
3m M DTT 
2% Dextrose
Chapter 2; From 
Dr. Kamakaka, 
Rohinton T. 
Personal 
commmunication
Extrusion
50mM HEPES pH 7.8 
150mM NaCI 
1mM EDTA 
14mM 2- 
mercaptoethanol 
5mM MgCI2
Halts inhibitor cocktail 
(Sigma)
Chapter 2; From 
Dr. Kamakaka, 
Rohinton T. 
Personal 
commmunication
Extraction
50mM HEPES pH 7.8 
325mM NaCI 
14mM 2- 
mercaptoethanol 
5mM MgCI2 
10% glycerol
Halts inhibitor cocktail 
(sigma) to 1x 
4mM Benzamidine 
50pM TPCK 
5-pM TLCK 
1mM PMSF 
10mM NEM
Chapter 2; From 
Dr. Kamakaka, 
Rohinton T. 
Personal 
commmunication
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Table 3. Raw data from MudPIT analysis of U-Tag affin ity purified proteins.
Parentheses represent gene names from Saccharomyces Genome Database 
(yeastgenome.org)
Retention Retention Time Pep
Peptide sequence T im e l Mean Score l Protein ID1
IDPSSDIANLK 33.55 33.55 32.6 ABP1_YEAST
SISIVGSYVGNR 36.55 36.55 32.86 ADH1_YEAST
YLAEFSSGDAR 29.9167 29.9167 31.73 BMH1_YEAST
IVSSIEQK 17.7333 17.7333 38.93 BMH1_YEAST
ATNASLEAYK 22.1333 22.1333 38.18 BMH1_YEAST
DSTLIMQLLR 56.1833 56.1833 30.31 BMH1_YEAST
YEEMVENMK 26.2833 26.2833 31.58 BMH1_YEAST
IRISSKK(SUM03_yeast_Try
psin (K)) 30.1167 30.1167 24.97 CSM3_YEAST
QTVAVGVIK 26.95 26.95 45.83 EF1A_YEAST
YAWVLDK 37.2333 37.2333 31.18 EF1A_YEAST
EF2_YEAST
STLTDSLVQR 31.1667 31.1667 31.37 (EFT2)
EF2_YEAST
AGEIVLAAR 26.95 26.95 34.39 (EFT2)
EF2_YEAST
VAFTVDQMR 33.8333 33.8333 33.01 (EFT2)
EF2_YEAST
ISPPVVAYR 32.1833 32.1833 42.05 (EFT2)
IGLDC(cam)ASSEFFK 44.5167 44.5167 39.81 EN01_YEAST
IEEELGDNAVFAGENFHHGD
KL 40.4333 40.4333 35.52 EN01_YEAST
TASGNIIPSSTGAAK 25.65 25.65 68.88 G3P3_YEAST
NGHWALDYTISR 37.8833 37.8833 47.91 GDE_YEAST
EANAGPNLDR 16.8667 16.8667 67.52 GDE_YEAST
VILFDLDSVR 50.5 50.5 48.81 GYS2_YEAST
APITVAQYK 26.15 26.15 55.72 GYS2_YEAST
EAQVDIEAIK 31.9333 31.9333 31.85 HS104_YEAST
ELQDIANPIMSK 38.6833 38.6833 57.18 HSP71_YEAST
M(ox)KEIAEAK 33.25 33.25 27.99 HSP75_YEAST
ELISNASDALDK 32.2833 32.2833 45.77 HSP82_YEAST
EILGDQVEK 24.7667 24.7667 33.33 HSP82_YEAST
NIYYITGESLK 38.3333 38.3333 36.97 HSP82_YEAST
LLDAPAAIR 32.6 32.6 29.04 HSP82_YEAST
YRPNC(cam)PIILVTR 36.7833 36.7833 39.35 KPYK1_YEAST
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Retention Retention Time Pep
Peptide sequence T im e l Mean S core l Protein ID1
(CDC19)
KPYK1_YEAST
TSIIGTIGPK 34.5167 34.5167 44.04 (CDC19)
KPYK1_YEAST
IMYVDYK 30.4667 30.4667 30.08 (CDC19)
RKEDDGDGVAWDSEQYTVP
EVQR 37.4167 37.4167 49.33 LEU3_YEAST
PHSG_YEAST
VVFVADYNVSK 36.25 36.25 43.81 (GPH1)
PHSG_YEAST
RLTpGFLPQEIK 42.5833 42.5833 52.39 (GPH1)
PHSG_YEAST
FIDHVETTLAR 31.5833 31.5833 43.6 (GPH1)
VLYVGNLDK 33.2333 33.2333 29.61 PUB1_YEAST
HSGNIQLDEIIEIAR 48.9667 48.9667 34.13 RL12A_YEAST
EILGTAQSVGC(cam)R 27.5833 27.5833 49.43 RL12A_YEAST
RLA0_YEAST
GTIEIVSDVK 33 33 37.9 (RPPO)
RLA0_YEAST
EYLEEYK 25.4667 25.4667 29.11 (RPPO)
RLA0_YEAST
SLFVVGVDNVSSQQMHEVR 42.35 42.35 88.65 (RPPO)
AVVESVGAEVDEAR 31.1 31.1 52.22 RLA4_YEAST
KVVGASVVVVK 26.3667 26.3667 20.5 RS12_YEAST
LVEGLANDPENKVPLIK 40.1333 40.1333 24.24 RS12_YEAST
LAVLSYYK 36.6833 36.6833 26.81 RS27A_YEAST
RPASSpDSLLK 38.4833 38.4833 34.82 SAS4_YEAST
FLYDGIR 34.0333 34.0333 31.36 SMT3_YEAST
LM(ox)EAFAK 21.25 21.25 27.49 SMT3_YEAST
IQADQTPEDLDMEDNDIIEA
HR 39.85 39.85 60.84 SMT3_YEAST
HEEALEVDSLIK 33.7667 33.7667 30.88 STE23_YEAST
LDVDELGDVAQ.K 37.1333 37.1333 49.47 TRX1_YEAST
SASEYDSALASGDK 24.1833 24.1833 70.92 TRX2_YEAST
LDVDEVSDVAQK 32.5667 32.5667 56.23 TRX2_YEAST
ENTQLMNR 17.85 17.85 57.56 ULP1_YEAST
STPNTVAFNSFFYTNLSER 51.9167 51.9167 41.52 ULP1_YEAST
RWLNDTIIEFFMK 62.6833 62.6833 37.88 ULP1_YEAST
TQIDKLDK 16.35 16.35 58.33 ULP1_YEAST
WLNDTIIEFFMK 70.6667 70.6667 36.43 ULP1_YEAST
DNIEITVR 34.6 34.6 67.01 ULP1_YEAST
YVMEESK 15.05 15.05 36.44 ULP1_YEAST
FIAHLILTDALK 48.5333 48.5333 62.91 ULP1 YEAST
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Retention Retention Time Pep
Peptide sequence T im e l Mean S co re l Protein ID1
YVM(ox)EESK 11.25 11.25 35.12 ULP1_YEAST
ENTQLM(ox)NR 13.6833 13.6833 54.67 ULP1_YEAST
VATE_YEAST
LLSEEALPAIR 40.55 40.55 40.12 (VMA4)
VATE_YEAST
EQSLDGIFEETK 40.5 40.5 47.89 (VMA4)
VATE_YEAST
ADQEYEIEK 21.3167 21.3167 50.76 (VMA4)
SNPPQVPSGWK 30.15 30.15 34.15 WWM1_YEAST
IVLSpFFLR 40.55 40.55 34.36 YD159_YEAST
EVHTNQDPLDVSASK 25.9 25.9 45.4 YP13B_YEAST
Table 4. Selected results from MudPIT analysis of U-Tag affin ity purified 
proteins. Full results from the mass spectrometry analysis are in table 3.
Sequence Gene Name Fragment Description
Y L A E F S S G D A R B M H 1 -1 1 4 - 3 - 3
I V S S I E Q K B M H 1 -2 Acidic, Dimeric
Role in signal transductionA T N A S L E A Y K B M H 1 -3
D S T L I M Q L L R B M H 1 -4
Y E E M V E N M K B M H 1 -5
S T L T D S L V Q R E F 2 -1 Elongation factor 2
A G E I V L A A R E F 2 -2
V A F T V D Q M R E F 2 -3
I S P P V V A Y R E F 2 - 4
F L Y D G I R S U M O -1 SUMO
L M ( o x ) E A F A K S U M O - 2
I Q A D Q T P E D L D M E D N D I I E A H R S U M O - 3
E Q S L D G I F E E T K V M A 4 -1 Peripheral membrane
A D Q E Y E I E K V M A 4 - 2 domain o f the vacuolar 
ATPaseL L S E E A L P A I R V M A 4 - 3
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Table 5. Primers used in PCR-based Myc tagging of SIZ1. Red letters 
represent SIZ1 sequence homology.
Primer Sequence
OOK662 5’-
AGAGCTGGACGGAACCGTCCAATTTTAGCCTCGTTTTTAGAATTCGAGCTCGTTTAAAC-
3’
OOK663 5’-
ATGGAAAACGCAAGATTATGGAAAGAAATACAACAGTGGTCGGATCCCCGGGTTAATTA
A-3’
References:
Alonso, A., D'Silva, S., Rahman, M., Meluh, P. B., Keeling, J., Meednu, N., 
Hoops, H. J., and Miller, R. K. (2012). The yeast homologue of the microtubule- 
associated protein Lis1 interacts with the sumoylation machinery and a SUMO- 
targeted ubiquitin ligase. Mol. Biol. Cell 23, 4552-4566.
Amberg, D.C., Burke, D.J. & Strathern, J.N., (2005). Methods in Yeast 
Genetics;A Cold Spring Harbor Laboratory Course Manual 2005th ed., cold 
spring harbors press.
Baba, D., Maita, N., Jee, J.-G., Uchimura, Y., Saitoh, H., Sugasawa, K., 
Hanaoka, F., et al. (2005). Crystal structure of thymine DNA glycosylase 
conjugated to SUMO-1. Nature, 435(7044), 979-82.
Baldwin, M. L., Julius, J. A., Tang, X., Wang, Y., & Bachant, J. (2009). The yeast 
SUMO isopeptidase Smt4/Ulp2 and the polo kinase Cdc5 act in an opposing 
fashion to regulate sumoylation in mitosis and cohesion at centromeres. Cell 
cycle (Georgetown, Tex.), 8(20), 3406-19.
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Barylko, B., Wang, L., Binns, D. D., Ross, J. A., Tassin, T. C., Collins, K. A., 
Jameson, D. M., and Albanesi, J. R (2010). The proline/arginine-rich domain is a 
major determinant of dynamin self-activation. Biochemistry 49, 10592-10594.
Bylebyl, G. R., Belichenko, I., and Johnson, E. S. (2003). The SUMO 
isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J. Biol. 
Chem. 278, 44113-44120.
Cao, L., Yu, W., Wu, Y., and Yu, L. (2009). The evolution, complex structures and 
function of septin proteins. Cell. Mol. Life Sci. 66, 3309-3323.
Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., & 
Varshavsky, A. (1989). A multiubiquitin chain is confined to specific lysine in a 
targeted short-lived protein. Science (New York, N.Y.), 243(4898), 1576-83.
Chen, C.-C., Chen, Y.-Y., Tang, l.-C., Liang, H.-M., Lai, C.-C., Chiou, J.-M., & 
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